Recombinant multi-species MAX protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MAX protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the basic helix-loop-helix leucine zipper (bHLHZ) family of transcription factors. It is able to form homodimers and heterodimers with other family members, which include Mad, Mxi1 and Myc. Myc is an oncoprotein implicated in cell proliferation, differentiation and apoptosis. The homodimers and heterodimers compete for a common DNA target site (the E box) and rearrangement among these dimer forms provides a complex system of transcriptional regulation. Mutations of this gene have been reported to be associated with hereditary pheochromocytoma. A pseudogene of this gene is located on the long arm of chromosome 7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]
The Alternative Names of target: Class D basic helix-loop-helix protein 4 (bHLHd4),MAX,Max,Myc-associated factor X,PDMCS,Protein max,bHLHd4,bHLHd5,bHLHd6,bHLHd7,bHLHd8
Go
to MAX products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP8804-Ag-1/ GM-Tg-hg-IP8804-Ag-2 | Human MAX protein | Human |
| GM-Tg-rg-IP8804-Ag-1/ GM-Tg-rg-IP8804-Ag-2 | Rat MAX protein | Rat |
| GM-Tg-mg-IP8804-Ag-1/ GM-Tg-mg-IP8804-Ag-2 | Mouse MAX protein | Mouse |
| GM-Tg-cynog-IP8804-Ag-1/ GM-Tg-cynog-IP8804-Ag-2 | Cynomolgus/Rhesus macaque MAX protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP8804-Ag-1/ GM-Tg-felg-IP8804-Ag-2 | Feline MAX protein | Feline |
| GM-Tg-cang-IP8804-Ag-1/ GM-Tg-cang-IP8804-Ag-2 | Canine MAX protein | Canine |
| GM-Tg-bovg-IP8804-Ag-1/ GM-Tg-bovg-IP8804-Ag-2 | Bovine MAX protein | Bovine |
| GM-Tg-equg-IP8804-Ag-1/ GM-Tg-equg-IP8804-Ag-2 | Equine MAX protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP8804-Ag-1/ GM-Tg-hg-IP8804-Ag-2;
GM-Tg-rg-IP8804-Ag-1/ GM-Tg-rg-IP8804-Ag-2;
GM-Tg-mg-IP8804-Ag-1/ GM-Tg-mg-IP8804-Ag-2; GM-Tg-cynog-IP8804-Ag-1/ GM-Tg-cynog-IP8804-Ag-2; GM-Tg-felg-IP8804-Ag-1/ GM-Tg-felg-IP8804-Ag-2; GM-Tg-cang-IP8804-Ag-1/ GM-Tg-cang-IP8804-Ag-2; GM-Tg-bovg-IP8804-Ag-1/ GM-Tg-bovg-IP8804-Ag-2; GM-Tg-equg-IP8804-Ag-1/ GM-Tg-equg-IP8804-Ag-2 |
| Products Name | MAX protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | MAX |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MAX protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.